TABLE 3

Morbidity Outcomes at Discharge Based on CDH Defect Size

All Patients (N = 2183)No. Missing DataDefect A (n = 370)Defect B (n = 979)Defect C (n = 644)Defect D (n = 177)Pa
Any morbidity1503 (74.6)167209 (61.8)612 (68.4)514 (85.4)159 (94.1)<.001
Pulmonary morbidity661 (30.4)644 (12.0)181 (18.5)312 (48.5)120 (68.2)<.001
 Supplemental oxygen417 (19.2)720 (5.5)95 (9.7)204 (31.8)94 (53.4)<.001
 Pulmonary medication524 (24.0)030 (8.1)133 (13.6)246 (38.2)111 (62.7)<.001
Neurologic morbidity447 (21.7)12540 (11.7)137 (15.0)183 (29.8)79 (45.7)<.001
 Abnormal neurologic examination437 (21.2)12540 (11.7)134 (14 6)177 (28.8)78 (45.1)<.001
 Neurologic medication40 (1.8)03 (0.8)8 (0.8)18 (2.8)10 (3.6)<.001
Gastrointestinal morbidity1349 (65.2)114183 (51.7)543 (58.8)474 (77.7)144 (85.2)<.001
 Supplemental tube feeds660 (30.5)2245 (12.2)183 (18.9)309 (48.6)119 (68.8)<.001
 Gastroesophageal reflux1227 (58.8)97162 (45.6)496 (53.3)437 (70.9)128 (74.4)<.001
  Diagnosed clinically903 (76.9)52144 (90.6)393 (83.3)298 (72.7)62 (50.0)<.001
  Diagnosed radiologically272 (23.1)15 (9.4)80 (16.7)112 (27.3)62 (50.0)<.001
   Nuclear scan33 (12.1)3 (20.0)8 (10.0)12 (10.7)9 (14.5)
   Upper gastrointestinal series219 (80.5)010 (66.7)69 (36.3)90 (80.4)48 (77.4).564
   pH probe20 (7.4)2 (13.3)3 (3.7)10 (8.9)5 (8.1)
  Medical therapy1008 (84.4)154 (96.3)450 (92.4)328 (78.3)74 (58.7)
  Surgical therapy184 (15.4)325 (3.1)35 (7.2)91 (21.7)51 (40.5)<.001
  No therapy given3 (0.2)1 (0.6)1 (0.2)0 (0)1 (0.8)
 Gastrointestinal medication353 (16.2)054 (14.6)145 (14.8)110 (17.1)43 (24.3).012
Median time on ventilator, d13 (7–24)377 (4–10)10 (7–16)22 (14–34)30 (22–50)<.001
Median hospital length of stay, d38 (23–69)422 (16–32)31 (22–47)62 (39–96)89 (64–132)<.001
  • Data are presented as n (%) or median (IQR).

  • a χ2 or Kruskal–Wallis rank tests comparing these patients with patients without morbidities.